Panagora Asset Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Panagora Asset Management's CLB Position: Q2 2026 in Review
Panagora Asset Management reduced its Core Laboratories (CLB) stake by 9.1% in Q2 2026, selling an estimated $71.2K and leaving 49,975 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #859.
Panagora Asset Management first reported a position in CLB in Q2 2013 and has held it in 21 quarters since. The position peaked at $2.33M in Q2 2017. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Panagora Asset Management held 49,975 shares of Core Laboratories worth $582K as of Q2 2026.
- Panagora Asset Management sold 4,987 Core Laboratories shares in Q2 2026, an estimated $71.2K.
- Core Laboratories made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #859 holding.
- Panagora Asset Management first reported a position in Core Laboratories in Q2 2013 and has held it in 21 quarters since.
- Panagora Asset Management's Core Laboratories position peaked at $2.33M in Q2 2017.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.